Rigel Pharmaceuticals, Inc.

Investors News & Events Contact Us
  • Home
  • Who We Are
    • Company Overview
    • Management Team
    • Board of Directors
    • Partners
  • Pipeline
    • Pipeline
      • Clinical Trials
      • Investigator Sponsored Research
      • Expanded Access Policy
    • Proprietary Programs
      • Warm AIHA
      • COVID-19
      • IRAK1/4
      • RIPK1
    • Partnered Programs
      • BerGenBio
      • Daiichi-Sankyo
      • Grifols
      • Kissei
      • Lilly
      • Medison
  • Products
  • Join Our Team
    • Life at Rigel
    • Our Values
    • Benefits
    • Current Openings
  • Investors
  • News & Events
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
    • Email Alerts
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • FAQ
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Analyst Coverage
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Events & Presentations
  • Email Alerts
Jan 06, 2011 7:30am EST

Rigel to Present at JP Morgan Healthcare Conference

Dec 09, 2010 7:30am EST

Rigel and AstraZeneca Awarded 'Licensing Deal of the Year' by Scrip for Fostamatinib Collaboration

Nov 23, 2010 7:30am EST

Rigel to Present at Piper Jaffray Health Care Conference

Nov 02, 2010 7:00am EDT

Rigel Announces Third Quarter 2010 Financial Results

Oct 28, 2010 7:30am EDT

Rigel Announces Presentations at Two Investor Conferences

Sep 29, 2010 7:30am EDT

Rigel Earns Milestone Payments From AstraZeneca

Sep 09, 2010 7:30am EDT

Rigel to Present at Stifel Nicolaus Healthcare Conference

Aug 03, 2010 7:30am EDT

Rigel Announces Second Quarter 2010 Financial Results

Jul 28, 2010 7:30am EDT

Rigel to Present at BMO Capital Markets Healthcare Conference

Jun 03, 2010 7:30am EDT

Rigel Announces Presentation at Three Investor Conferences

  • Previous
  • 1…
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • …34
  • Next
RSS
  • Email Alerts
  • RSS News Feed
Terms of Use Privacy Policy

© 2022 Rigel Pharmaceuticals, Inc. All Rights Reserved.

TAVALISSE, TAVLESSE, RIGEL and the Rigel arc logo are trademarks of Rigel Pharmaceuticals, Inc.

Facebook Twitter Linkedin